Researchers asked whether there are any signs or symptoms that predict later diagnosable bipolar disorder with reasonable accuracy. If so, this would be useful for prognosis and preparation, but even more importantly, encourage efforts targeting prevention.
Although a number of observational studies point to an association between conventional antipsychotic agents and increased risk in older patients, new research suggests such findings may have been flawed.
The prevalence of chronic hepatitis C virus infection is among the highest in patients with severe underlying mental illness. Here: clinical information on the interface of HCV infection and psychiatric disorders.
Psoriasis, a chronic inflammatory, autoimmune skin disorder, is associated with both genetic and environmental factors. It has important treatment implications for patients who have psychiatric disorders.
There are probably few health care professionals who are unaware of the concerns about the apparent overprescription of opioids. However, we have had only limited information on how good a job physicians may actually be doing in prescribing these medications.
In this video, Dr Karl Doghramji, describes the various agents available for managing sleep disorders and discusses the adverse effects associated with over-the-counter, nutraceutical, and prescription sleep aids.
What happens when our patients get pregnant or plan to get pregnant? What if psychiatric illness manifests during pregnancy or the perinatal period? Dr Elizabeth Fitelson answers these questions and more in this video.
What do we know about the relative efficacy of current medication and therapy for OCD? This question answered and highlights of recent studies, future directions, and causes are summarized in this video.
It is important to monitor and alter psychotropic medications and dosages in older patients as needed. This slideshow serves as quick reference on the effects of pharmacokinetic and pharmacodynamic changes in the elderly.
The psychiatrist’s role is to act as a consultant to maximize the likelihood of a successful taper and discontinuation and to minimize collateral morbidities or withdrawal complications. This slideshow features common scenarios in which a planned discontinuation of psychotropic medications occurs.